Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 383 followers
Latest posts
Last updated about 12 hours ago
Bayer edges onto Boehringer's turf with FDA nod for HER2-mutated lung cancer med Hyrnuo
about 12 hours ago
Bayer's Hyrnuo is catching up to Boehringer Ingelheim's rival Hernexeos with an...
Moderna blueprints $140M plant in bid to bring end-to-end mRNA production to US
about 13 hours ago
With a $140 million investment, Moderna will build a new facility at...
Novartis maps out plan for 'flagship' production hub in NC, eyes 700 hires
about 14 hours ago
The company expects the newly revealed production "hub" will add 700 new...
Agios readies FDA push in sickle cell disease despite mixed ph. 3 results, shares plummet
about 16 hours ago
Agios’ shares nosedived by 49% on Wednesday morning after the company revealed...
Celltrion to widen US manufacturing reach with $478M investment at former Lilly plant
about 17 hours ago
Two months after Celltrion bought a U.S. manufacturing facility from Eli Lilly...
After Lundbeck's surprise bid, Alkermes sweetens deal to acquire Avadel
about 19 hours ago
Alkermes and Avadel have reached an accord on a new offer that...
Regulatory tracker: Lilly's Alzheimer med cleared to reach India with new approval
about 19 hours ago
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
Teva calls on startups to Rise to the occasion with open innovation platform for 7 biopharma challenges
about 20 hours ago
Teva Pharmaceutical is launching its first global innovation platform, challenging startups to...
Rising Stars: How Spectrum Science’s Ali Sullivan ‘fell into’ pharma marketing
about 23 hours ago
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Sullivan reflected...
Sackler family, Purdue Pharma's $7.4B settlement plan wins bankruptcy judge's approval
1 day ago
The bankruptcy reorganization plan will deliver $7.4 billion to creditors, including an...
Arrowhead strikes true with 1st FDA approval of genetic disorder drug, but Ionis competition looms
1 day ago
With a fresh FDA endorsement for its drug plozasiran, Pasadena-based Arrowhead Pharmaceuticals...
'We're built for it': Why Cytokinetics doesn't want Big Pharma support to help it supersede Camzyos
1 day ago
Cytokinetics may be counting down the days until the FDA decides whether...